Dr. Yehuda Deutsch is a board-certified hematologist-oncologist dedicated to improving care of patients with cancer. He grew up in South Florida and earned his medical degree from the University of Miami Miller School of Medicine, where he was elected into the national Alpha Omega Alpha Honor Medical Society. He completed his residency and fellowship at Jackson Memorial Hospital and the University of Miami, where he was the recipient of the Peter A. Cassileth award for outstanding clinical judgment, enthusiasm for learning and compassionate care. 

Dr. Deutsch has a special focus in hematologic malignancies, including leukemia, lymphoma and myeloma. He is dedicated to improving patient care through teaching and clinical research. Dr. Deutsch was selected to participate in the International Methods in Clinical Cancer Research Workshop, where he advanced his interest in experimental therapeutics of leukemia. He continues to serve as clinical investigator in numerous clinical trials. He has numerous publications and has given presentations at both local and international meetings.

Hospital Affiliations

• Memorial Hospital Miramar
• Memorial Hospital West
• Memorial Regional Hospital

Gender

• Male

• Hematologic malignancies
• Leukemia
• Lymphoma
• Myeloma

Education

University Of Miami School Of Medicine, 2009

Residency

University of Miami - Jackson Memorial Hospital - Internal Medicine Prog, 2012, Internal Medicine

Fellowships

Jackson Memorial Hospital - Hematology/Oncology, 2015, Oncology and Hematology

Certifications

American Board of Internal Medicine-Hematology

American Board of Internal Medicine-Medical Oncology

Publications

• View Dr. Yehuda Deutsch's publications on PubMed

Research

• Division of Hematology/Oncology, UMMSM / SCCC, 2013–2015
• Quality improvement in non-malignant hematology clinical care and education
• Experimental therapeutics in myeloid cancers
• CD30 expression in Adult T-cell Leukemia-Lymphoma: evaluating the expression of CD30 in HTLV-associated Adult T-cell Leukemia-Lymphoma, the effects of targeting CD30 and methods to increase CD30 expression in ATLL or improve the effect of CD30 targeted therapy 

Professional Organizations

• American Society of Clinical Oncology
• American Society of Hematology
• American College of Physicians
• European Society for Medical Oncology

Presentations

Abstracts and Poster Presentations:

• Monge J, Gologorsky D, Gallastegui N, Deutsch Y, Benedetto P. Waldenström Macroglobulinemia Presenting as Bilateral Central Retinal Vein Occlusion in a Young Adult. Poster presentation at the Florida Chapter American College of Physicians 2015 Annual Scientific Meeting, September 12, 2015. Tampa, FL, USADeutsch YMonge J, Gologorsky D, Gallastegui N, 
• Deutsch YE, Vega F, Swords RT. Clinical Utility of Morphological Evaluation of Day 14 Bone Marrow Biopsies in Acute Myeloid Leukemia Patients Undergoing Standard Induction Chemotherapy: Time to Change Practice?; Poster Presentation: ASH 2014
• Deutsch YE, Perez A, Watts JM, Swords RT, Zelent A. Sodium Salicylate Has a Priming Effect When Combined with Azacitidine in Pre-Clinical Models of AML; Poster Presentation: ASH 2014
• Deutsch YE, Dammrich DJ, Fabregas JC, Pimentel A, Stefanovic A, Hoffman JE. Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population. Blood 2013 vol. 122 no. 21 5399
• Deutsch YE, Rocha-Lima C., et al. (2012, January). Cholangiocarcinoma: A Joint Cancer Database Analysis. Poster Presentation: ASCO GI Symposium 2012; San Francisco, California

Oral Presentations:

• A Rare Case of Fatal Hemolysis: Pulmonary/Critical Care Divisional Grand Rounds; University of Miami; December 18, 2013
• CD30 expression in Adult T-cell Leukemia-Lymphoma, is it targetable?: Hematology/Oncology Divisional Grand Rounds; Sylvester Comprehensive Cancer Center; November 20, 2013
• Growth Factors in Acute Myeloid Leukemia: Hematology/Oncology Divisional Grand Rounds; Sylvester Comprehensive Cancer Center; January 30, 2013
• Mixed Phenotype Acute Leukemia: Hematology/Oncology Divisional Grand Rounds; Sylvester Comprehensive Cancer Center; September 12, 2012

Journal Articles:

• Deutsch YE, Lossos IS, Rosenblatt JD. Brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: a review of clinical experience and future directions. International Journal of Hematologic Oncology, December 2013, Vol. 2, No. 6, Pages 455-465
• Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. CD30: An important new target in hematologic malignancies. Leuk Lymphoma 2011;52(9):1641-54. PMID: 21619423
• Montero AJ, Diaz-Montero CM, Deutsch YE, et al. Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. Breast Cancer Res Treat 2011. PMID: 22138748 Deutsch YE Montero AJ, Diaz-Montero CM, 

Teaching Responsibilities:

• University of Miami Miller School of Medicine
  • Lecturer in Hematology-Oncology Core Curriculum
• Division of Hematology-Oncology, University of Miami
  • Founder and Coordinator of Non-Malignant Hematology teaching conference and fellows’ educational course.

Editorial Responsibilities:

• Review manuscripts for peer-reviewed journals
• Hematology, Expert Opinion On Therapeutic Targets

Other Professional Activities:

• ACS Vital Talk Workshop; November 2013

Awards

• Peter A. Cassileth award for outstanding clinical judgment, enthusiasm for learning and compassionate care; June 2015
• ECCO-AACR-EORTC-ESMO Workshop "Methods in Clinical Cancer Research" Flims, Switzerland; June 2014
• HTRS Coagulation Disorders Workshop; April 2014
• Alpha Omega Alpha Honor Medical Society, University of Miami Miller School of Medicine
• Medical School Trustee Scholarship, University of Miami Miller School of Medicine
• Summa Cum Laude, Yeshiva University, New York, New York
• Schottenstein Honors Program, Yeshiva University, New York, New York